On May 1, 2009, there was a recall of fourteen Hydroxycut diet-aid products stemming from a number of reports that people using the products were developing significant liver issues and other health issues. Less than a week later, on May four, the first Hydroxycut class action lawsuit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Case alleges company failure in informing the public about potential risks of the products. Naturally, it’s too shortly to grasp the suit is going to turn out, but if the company had information which it did not reveal to buyers, it should definitely be held accountable.

A class action lawsuit is filed by a bunch of folk, all of whom have similar claims against a certain company. Filing a class action is just as effective, and far less dear, than filing an individual suit. As a rule, filing a class action lawsuit won’t cost you anything unless there’s a settlement. At that point, the attorney who handled the suit will take his fees from the compensation that got given and then share the leftover funds to the accusers in the case. Since this is the case, you will be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the reasons that class action suits became so popular.

The first class action suit against Iovate was filed in Canada where the company is found and represents all Canadian voters who sustained health problems due to Hydroxycut products. The FDA recall occurred in the U. S. Where twenty-three cases of liver disorders and other health issues had been reported. Health Canada failed to receive any reports of liver damage due to the diet products, but they did receive seventeen reports concerning people who sustained respiration, neurological, heart, and gut issues as a result of Canadians using the products.

The Hydroxycut Settlement Suit alleges the company sold the company sold the products without properly informing the public of the health risks that they could exposing buyers to. The complaint states the company failed to publish the data on the product labels saying that users could run the risk of liver and kidney damage as well as gut, cardio, respiratory, and neurological problems. The suit goes on to allege that this was an obvious omission on the part of the company which purposely misled clients concerning the safety of the products.

This entry was posted on Friday, June 26th, 2009 at 8:22 am and is filed under Health Center, Helping People, University Of Legal Matters. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.